Cereno Scientific AB (publ)

kr 1.63As of Sun 8 Nov 2026, 12:00 UTC
STO:CRNO-BHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (12.12%)
Div yield —
ROE (61.92%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.26)
PE TTM —
TSR TTM (77.63%)
Mkt cap kr 528.9M
ROIC (13.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 2.05
25.72%
(49.48%)
Hold 7|0|3|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.03
0.03
0.03
0.03
11.56%
11.94%
19.92%
33.10%
Revenuekr M
34.67
35.89
37.23
36.53
6.94%
6.08%
7.64%
8.23%
Peers (US$53.47M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
7.664
0.268
0.266
EBIT/Intx
0.211
0.146
0.194
Own earn%
(47.88)
(10.56)
(8.21)
Sh yield%
38.59
37.22
39.08
Owners
Insiders/Inst%
3.45
40.77
Short interest%
3.18
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
11–23
$1 testx
0.0
Incr. ROIC%
6